Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionel Spielmann

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of the Rheumatic Diseases|August 19, 2019
Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Knevel and HuizingaAlain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|September 22, 2019
Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro <i>et al</i>Lionel Spielmann, François Séverac, Alain Meyer
Annals of the Rheumatic Diseases|July 26, 2019
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: 'On using machine learning algorithms to define clinical meaningful patient subgroups' by Pinal-Fernandez and MammenAlain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|August 1, 2019
Response to 'Augmented vs. artificial intelligence for stratification of patients with myositis' by Mahler <i>et al</i>Alain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|December 6, 2019
Response to: 'Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients' by Ogawa-Momohara <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
Annals of the Rheumatic Diseases|March 28, 2020
Response to: 'Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies' by Yang <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
ACR Open Rheumatology|October 21, 2021
The crossbow sign in extracranial giant cell arteritisPierre-Marie Duret, Lionel Spielmann, Laurent Messer
Annals of the Rheumatic Diseases|August 21, 2020
Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina <i>et al</i>Pierre-Marie Duret, Lionel Spielmann, Laurent Messer
Clinical Rheumatology|February 17, 2020
At the crossroads of gout and psoriatic arthritis: "psout"Renaud Felten, Pierre-Marie Duret, Jacques-Eric Gottenberg, et al.
EULAR Rheumatology Open|June 29, 2026
Professional positioning of general practitioners in the management of postmenopausal osteoporosis in community medicineLionel Spielmann, Fleur Heimendinger, Pierre-Marie Duret, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|August 19, 2019
Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Knevel and HuizingaAlain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|September 22, 2019
Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro <i>et al</i>Lionel Spielmann, François Séverac, Alain Meyer
Annals of the Rheumatic Diseases|July 26, 2019
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: 'On using machine learning algorithms to define clinical meaningful patient subgroups' by Pinal-Fernandez and MammenAlain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|August 1, 2019
Response to 'Augmented vs. artificial intelligence for stratification of patients with myositis' by Mahler <i>et al</i>Alain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|December 6, 2019
Response to: 'Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients' by Ogawa-Momohara <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
Annals of the Rheumatic Diseases|March 28, 2020
Response to: 'Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies' by Yang <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
ACR Open Rheumatology|October 21, 2021
The crossbow sign in extracranial giant cell arteritisPierre-Marie Duret, Lionel Spielmann, Laurent Messer
Annals of the Rheumatic Diseases|August 21, 2020
Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina <i>et al</i>Pierre-Marie Duret, Lionel Spielmann, Laurent Messer
Clinical Rheumatology|February 17, 2020
At the crossroads of gout and psoriatic arthritis: "psout"Renaud Felten, Pierre-Marie Duret, Jacques-Eric Gottenberg, et al.
EULAR Rheumatology Open|June 29, 2026
Professional positioning of general practitioners in the management of postmenopausal osteoporosis in community medicineLionel Spielmann, Fleur Heimendinger, Pierre-Marie Duret, et al.
Pageof 2